Showing 2321-2330 of 3069 results for "".
The Best Asset Protection Implementation is Not Asset Protection... Is Yours?
https://practicaldermatology.com/topics/practice-management/the-best-asset-protection-implementation-is-not-asset-protection-is-yours/21472/A review of plans that will offer protection if needed and help build wealth along the way.State Legislation of EHRs: A Sweeping Precedent?
https://practicaldermatology.com/topics/practice-management/state-ehr-legislation-a-new-precedent/21483/A new law in Massachusetts requires all licensed physicians to be using an EHR by 2015.Analyzing the New Consensus Statement on Immunotherapy for Melanoma
https://practicaldermatology.com/topics/skin-cancer-photoprotection/analyzing-the-new-consensus-statement-on-immunotherapy-for-melanoma/21506/Here Comes the Sunshine: What you Should Know
https://practicaldermatology.com/topics/practice-management/here-comes-the-sunshine-what-you-should-know/21523/In-Review: Two New Melanoma Agents Approved
https://practicaldermatology.com/topics/skin-cancer-photoprotection/in-review-two-new-melanoma-agents-approved/21534/Utilizing genetic abnormalities, new therapies are carving out new possibilities for melanoma treatment.PV-10: Update on an Emerging Melanoma Therapy
https://practicaldermatology.com/topics/skin-cancer-photoprotection/pv-10-update-on-an-emerging-melanoma-therapy/22971/Last year, Practical Dermatology reviewed data for an intralesional therapy for melanoma. Now a phase III trial appears imminent.Devices in Dermatology
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/devices-in-dermatology/22955/The State of the ArtIntegrating Excimer Laser Therapy for Psoriasis and Vitiligo
https://practicaldermatology.com/topics/psoriasis/integrating-excimer-laser-therapy-for-psoriasis-and-vitiligo/22959/New patient and practice support programs may expand interest in laser therapy for common medical conditions.Re-Considering the Psychological Components of Psoriasis
https://practicaldermatology.com/topics/psoriasis/re-considering-the-psychological-components-of-psoriasis/22962/With convincing data that show that psoriasis directly inhibits patients' daily activities and quality of life, clinicians must emphasize trust and empathy.Biosimilar Medicines in Dermatology: Key Aspects
https://practicaldermatology.com/topics/psoriasis/biosimilar-medicines-in-dermatology-key-aspects/22929/After the recent enactment of a specific approval pathway for biosimilars and publication of the first draft guidelines on biosimilar product development by the FDA, biosimilars are expected to be available in the US soon.